|
|
Article: ART Time Domain Technology Applications to Be Presented at the World Molecular Imaging Congress in Montreal, Canada; Presentations highlight ongoing research for ART's Optix, SoftScan, and Fenestra products.
- Article from:
- Marketwire Canada
- Article date:
- September 24, 2009
CopyrightCOPYRIGHT 2009 Canadian Corporate News. News Provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MONTREAL, CANADA, Sep 24, 2009 (Marketwire via COMTEX) -- ART Advanced Research Technologies Inc. ("ART") (TSX:ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, will be featured in several scientific research presentations based on ART's SoftScan(R) optical imaging device, Optix(R) in vivo fluorescence optical imaging system, and Fenestra(R) imaging agent for microCT, at the World Molecular Imaging Congress (WMIC), being held at the Palais des congres in Montreal, Canada, from September 23 to 26, 2009.
Thursday, September 24, 2009 - 4:00 PM to 5:30 PM
Poster ...